Viking Therapeutics' stock recently tanked after reporting clinical trial results for an oral anti-obesity candidate. The ...

JAK inhibitors for rheumatoid arthritis demonstrate higher risks for cancer vs. biologic disease-modifying antirheumatic drugs, particularly among older patients and those with higher disease activity ...

Soleno Therapeutics CEO responds to a 415-page short-seller report alleging safety issues tied to the company's newly approved therapy.